501 related articles for article (PubMed ID: 24534133)
1. Diagnosis and management of complement mediated thrombotic microangiopathies.
Cataland SR; Wu HM
Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
[TBL] [Abstract][Full Text] [Related]
2. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
Cataland SR; Wu HM
Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
[TBL] [Abstract][Full Text] [Related]
3. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
[TBL] [Abstract][Full Text] [Related]
4. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathies.
Rosove MH
Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
[TBL] [Abstract][Full Text] [Related]
6. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
7. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
8. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
9. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome.
Cataland SR; Wu HM
Blood; 2014 Apr; 123(16):2478-84. PubMed ID: 24599547
[TBL] [Abstract][Full Text] [Related]
10. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
Williams LA; Marques MB;
Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
12. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
Laurence J
Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the management of atypical hemolytic uremic syndrome.
Cataland SR
Clin Adv Hematol Oncol; 2012 Aug; 10(8):537-9. PubMed ID: 23073053
[No Abstract] [Full Text] [Related]
14. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
15. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
Scully M; Goodship T
Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
[TBL] [Abstract][Full Text] [Related]
16. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update.
Tsai HM
Hematol Oncol Clin North Am; 2013 Jun; 27(3):565-84. PubMed ID: 23714312
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.
Cataland SR; Holers VM; Geyer S; Yang S; Wu HM
Blood; 2014 Jun; 123(24):3733-8. PubMed ID: 24695849
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of TMA based on Japanese clinical guides].
Wada H; Hasegawa K; Watanabe M
Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
[TBL] [Abstract][Full Text] [Related]
20. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
Intern Med J; 2018 Jun; 48(6):624-636. PubMed ID: 29582550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]